Gay and Bisexual Men’s Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study
- 24 Downloads
Since FDA approval in 2012, HIV pre-exposure prophylaxis (PrEP) has been adopted by key populations, including gay and bisexual men (GBM), to reduce their HIV transmission risk. Given that PrEP is optimally effective when taken as prescribed, it is critical to understand the adherence strategies GBM use. We conducted one-on-one, semi-structured interviews with GBM taking PrEP in 2015–2016 (n = 103). Using thematic analysis, we identified six adherence strategies, with most participants (84.3%) utilizing multiple strategies to maintain adequate adherence: (1) integrating PrEP into part of a daily routine, (2) using a pillbox, (3) cognitive strategies/visual cues, (4) setting recurring smartphone alarms or reminders, (5) keeping medication on oneself at all times, and (6) partner or peer support for reminders and/or pill sharing. Overall, participants reported high PrEP adherence (M = 1.6 missed doses in the prior 30 days), though nearly all described missing at least one dose unintentionally in the past. Participants credited their high levels of adherence in part to the strategies they adopted. Providers working with GBM prescribed PrEP, especially patients reporting difficulties with adherence, might consider recommending any or all of the six strategies described in this study.
KeywordsPre-exposure prophylaxis (PrEP) Adherence Gay and bisexual men HIV Qualitative data
The authors would like to acknowledge the contributions of other members of the PrEP & Me study team (Mark Pawson, Demetria Cain, Brian Salfas, Chloe Mirzayi, Juan Castiblanco, and Ruben Jimenez), and other staff from the Center for HIV/AIDS Educational Studies and Training (Chris Hietikko, Tina Koo, Desmond Dutcher, and Carlos Ponton). Finally, we thank Shoshana Kahana at NIDA and all of our participants who participated in PrEP & Me.
PrEP & Me was funded by the National Institute of Drug Abuse (R21- DA039019, PI: Grov).
Compliance with Ethical Standards
Conflicts of Interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH). NIDA/NIH had no role in the production of this manuscript nor necessarily endorses its findings.
- Bush, S., Magnuson, D., Rawlings, K., Hawkins, T., McCallister, S., & Mera Giler, R. (2015). Racial Characteristics of FTC/TDF for pre-exposure prophylaxis (prep) users in the US Paper presented at the ASM Microbe 2016, Boston.Google Scholar
- Calabrese, S. K., & Underhill, K. (2015). How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: A call to destigmatize “Truvada Whores”. American Journal of Public Health, 105, 1960–1964Google Scholar
- Delaney, K. P., Sanchez, T., Bowles, K., Oraka, E., DiNenno, E., & Sullivan, P. (2016). Awareness and use of PrEP appear to be increasing among internet samples of US MSM. Paper presented at the Conference on Retroviruses and Opportunistic Infections, Boston.Google Scholar
- Flash, C., Landovitz, R., Mera Giler, R., Ng, L., Magnuson, D., Bush Wooley, S., & Rawlings, K. (2014). Two years of Truvada for pre-exposure prophylaxis utilization in the US. Journal of the International AIDS Society, 17, 19730. https://doi.org/10.7448/IAS.17.4.19730.CrossRefPubMedPubMedCentralGoogle Scholar
- Gilmore, H. J., Liu, A., Koester, K. A., Amico, K. R., McMahan, V., Goicochea, P., et al. (2013). Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx Pre-Exposure Prophylaxis Trial in San Francisco. AIDS Patient Care and STDs, 27, 560–566.CrossRefGoogle Scholar
- Golub, S. A., Gamarel, K. E., Rendina, H. J., Surace, A., & Lelutiu-Weinberger, C. L. (2013). From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care and STDs, 27, 248–254.CrossRefGoogle Scholar
- Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., et al. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. The Lancet Infectious Diseases, 14, 820–829.CrossRefGoogle Scholar
- Kibengo, F. M., Ruzagira, E., Katende, D., Bwanika, A. N., Bahemuka, U., Haberer, J. E., et al. (2013). Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial. PLoS One, 8, e74314.Google Scholar
- Lam, W. Y., & Fresco, P. (2015). Medication adherence measures: an overview (pp. 12). BioMed Research International. https://doi.org/10.1155/2015/217047.
- Liu, A. Y., Hessol, N. A., Vittinghoff, E., Amico, K. R., Kroboth, E., Fuchs, J., et al. (2014). Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. AIDS Patient Care and STDs, 28, 622–627.CrossRefGoogle Scholar
- Mera Giler, R., Magnuson, D., Trevor, H., Bush, S., Rawlings, K., & McCallister, S. (2017). Changes in truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States: (2012-2016). Paper presented at the 9th International AIDS Society Conference on HIV Science, Paris, France.Google Scholar
- Miles, M. B., & Huberman, M. (1994). Qualitative data analysis: an expanded sourcebook. Thousand Oaks: Sage Publications.Google Scholar
- Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., et al. (2015). On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New England Journal of Medicine, 373, 2237–2246.Google Scholar
- Neuendorf, K. A. (2002). The content analysis guidebook. Thousand Oaks: Sage.Google Scholar
- Parsons, J. T., Rendina, H. J., Grov, C., Ventuneac, A., & Mustanski, B. (2015). Accuracy of highly sexually active gay and bisexual men's predictions of their daily likelihood of anal sex and its relevance for intermittent event-driven HIV pre-exposure prophylaxis. Journal of Acquired Immune Deficiency Syndromes, 68, 449–455.CrossRefGoogle Scholar
- Patrick, R., Forrest, D., Cardenas, G., Opoku, J., Magnus, M., Phillips, G. I., et al. (2017). Awareness, willingness, and use of pre-exposure prophylaxis among men who have sex with men in Washington, DC and Miami-Dade County, FL: National HIV behavioral surveillance, 2011 and 2014. JAIDS Journal of Acquired Immune Deficiency Syndromes, 75, S375–S382.CrossRefGoogle Scholar
- Patton, M. Q. (1990). Qualitative evaluation research (2nd ed.). Newbury Park: Sage Publications, Inc..Google Scholar
- Petersen, M. L., Wang, Y., van der Laan, M. J., Guzman, D., Riley, E., & Bangsberg, D. R. (2007). Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clinical Infectious Diseases, 45, 908–915.CrossRefGoogle Scholar
- Pop-Eleches, C., Thirumurthy, H., Habyarimana, J. P., Zivin, J. G., Goldstein, M. P., de Walque, D., et al. (2011). Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS, 25, 825–834.CrossRefGoogle Scholar
- Ronis, D. L., Yates, J. F., & Kirscht, J. P. (1989). Attitudes, decisions, and habits as determinants of repeated behavior. In A. R. Pratkan, S. J. Breckler, & A. G. Greenwald (Eds.), Attitude structure and function (pp. 213–239). Hillsdale: Lawrence Erlbaum Associates, Publishers.Google Scholar
- Saldaña, J. (2013). The coding manual for qualitative research (2nd ed.). Thousand Oaks: Sage.Google Scholar
- Scanlon, M. L., & Vreeman, R. C. (2013). Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl), 5, 1–17.Google Scholar
- Shet, A., Costa, A. D., Kumarasamy, N., Rodrigues, R., Rewari, B. B., Ashorn, P., et al. (2014). Effect of mobile telephone reminders on treatment outcome in HIV: Evidence from a randomised controlled trial in India. BMJ [British Medical Journal], 349, g5978.Google Scholar
- Simoni, J. M., Pearson, C. R., Pantalone, D. W., Crepaz, N., & Marks, G. (2006). Efficacy of highly active antiretroviral therapy interventions in improving adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. Journal of Acquired Immune Deficiency Syndromes, 43, 523–535.CrossRefGoogle Scholar
- Snowden, J. M., Chen, Y. H., McFarland, W., & Raymond, H. F. (2017). Prevalence and characteristics of users of pre-exposure prophylaxis (PrEP) among men who have sex with men, San Francisco, 2014 in a cross-sectional survey: Implications for disparities. Sexually Transmitted Infections, 93, 52–55.CrossRefGoogle Scholar
- Stawarz, K., Cox, A. L., & Blandford, A. (2015). Beyond self-tracking and reminders: designing smartphone apps that support habit formation. Paper presented at the Proceedings of the 33rd annual ACM conference on human factors in computing systems.Google Scholar
- Tangmunkongvorakul, A., Chariyalertsak, S., Amico, K. R., Saokhieo, P., Wannalak, V., Sangangamsakun, T., et al. (2013). Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care, 25, 961–967. https://doi.org/10.1080/09540121.2012.748871.CrossRefPubMedGoogle Scholar
- Taylor, S. W., Psaros, C., Pantalone, D. W., Tinsley, J., Elsesser, S. A., Mayer, K. H., & Safren, S. A. (2017). “Life-Steps” for PrEP adherence: Demonstration of a CBT-based intervention to increase adherence to preexposure prophylaxis (PrEP) medication among sexual-minority men at high risk for HIV acquisition. Cognitive and Behavioral Practice, 24, 38–49.CrossRefGoogle Scholar
- Van der Elst, E. M., Mbogua, J., Operario, D., Mutua, G., Kuo, C., Mugo, P., et al. (2013). High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: Qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS and Behavior, 17, 2162–2172.CrossRefGoogle Scholar